Korb-Pap, A., J. Bertrand, J. Sherwood, and T. Pap. 2016. Stable activation of fibroblasts in rheumatic arthritis - causes and consequences. Rheumatology 55: 64–67.
Huber, L.C., O. Distler, I. Tarner, R.E. Gay, S. Gay, and T. Pap. 2006. Synovial fibroblasts: Key players in rheumatoid arthritis. Rheumatology (Oxford) 45: 669–675.
Yokota, K., T. Miyazaki, M. Hirano, Y. Akiyama, and T. Mimura. 2006. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Journal of Rheumatology 33: 463–471.
Luo, X.J., X.R. Mo, and L.L. Zhou. 2012. The effect of Hsp72 on IL-6, IL-8 expression and activation of NF-kappaB in synoviocytes of rheumatoid arthritis. Zhongguo Ying Yong Sheng Li Xue Za Zhi 28: 336–339.
Li, Y., and W. Zhang. 2017. IL-6: The next key target for rheumatoid arthritis after TNF-alpha. Sheng Wu Gong Cheng Xue Bao 33: 36–43.
Quinonez-Flores, C.M., S.A. Gonzalez-Chavez, and C. Pacheco-Tena. 2016. Hypoxia and its implications in rheumatoid arthritis. Journal of Biomedical Science 23: 62.
Fearon, U., M. Canavan, M. Biniecka, and D.J. Veale. 2016. Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis. Nature Reviews Rheumatology 12: 385–397.
Muz, B., M.N. Khan, S. Kiriakidis, and E.M. Paleolog. 2009. Hypoxia The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Research & Therapy 11: 201.
Niu, X., Y. Chen, L. Qi, G. Liang, Y. Wang, L. Zhang, Y. Qu, and W. Wang. 2019. Hypoxia regulates angeogenic-osteogenic coupling process via up-regulating IL-6 and IL-8 in human osteoblastic cells through hypoxia-inducible factor-1alpha pathway. Cytokine 113: 117–127.
D’Ignazio, L., and S. Rocha. 2016. Hypoxia induced NF-kappaB. Cells 5: 10.
Deng, W., X. Feng, X. Li, D. Wang, and L. Sun. 2016. Hypoxia-inducible factor 1 in autoimmune diseases. Cellular Immunology 303: 7–15.
Guan, S.Y., R.X. Leng, J.H. Tao, X.P. Li, D.Q. Ye, N. Olsen, S.G. Zheng, and H.F. Pan. 2017. Hypoxia-inducible factor-1alpha: A promising therapeutic target for autoimmune diseases. Expert Opinion on Therapeutic Targets 21: 715–723.
Guo, X., and G. Chen. 2020. Hypoxia-inducible factor is critical for pathogenesis and regulation of immune cell functions in rheumatoid arthritis. Frontiers in Immunology 11: 1668.
Ryu, J.H., C.S. Chae, J.S. Kwak, H. Oh, Y. Shin, Y.H. Huh, C.G. Lee, Y.W. Park, C.H. Chun, Y.M. Kim, S.H. Im, and J.S. Chun. 2014. Hypoxia-inducible factor-2alpha is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Biology 12: e1001881.
Nonomura, Y., F. Mizoguchi, A. Suzuki, T. Nanki, H. Kato, N. Miyasaka, and H. Kohsaka. 2009. Hypoxia-induced abrogation of contact-dependent inhibition of rheumatoid arthritis synovial fibroblast proliferation. Journal of Rheumatology 36: 698–705.
Sabi, E.M., A. Singh, Z.M. Althafar, T. Behl, A. Sehgal, S. Singh, N. Sharma, S. Bhatia, A. Al-Harrasi, H.M. Alqahtani, and S. Bungau. 2022. Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis. Inflammopharmacology 30: 737–748.
Malkov, M.I., C.T. Lee, and C.T. Taylor. 2021. Regulation of the hypoxia-inducible factor (HIF) by pro-inflammatory cytokines. Cells 10: 2340.
Thornton, R.D., P. Lane, R.C. Borghaei, E.A. Pease, J. Caro, and E. Mochan. 2000. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. The Biochemical Journal 350 (Pt 1): 307–312.
Hellwig-Burgel, T., K. Rutkowski, E. Metzen, J. Fandrey, and W. Jelkmann. 1999. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561–1567.
Westra, J., E. Brouwer, R. Bos, M.D. Posthumus, B. Doornbos-van der Meer, C.G. Kallenberg, and P.C. Limburg. 2007. Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts. Annals of the New York Academy of Sciences 1108: 340–348.
Georganas, C., H. Liu, H. Perlman, A. Hoffmann, B. Thimmapaya, and R.M. Pope. 2000. Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: The dominant role for NF-kappa B but not C/EBP beta or c-Jun. The Journal of Immunology 165: 7199–7206.
Luo, X., X. Zuo, Y. Zhou, B. Zhang, Y. Shi, M. Liu, K. Wang, D.R. McMillian, and X. Xiao. 2008. Extracellular heat shock protein 70 inhibits tumour necrosis factor-alpha induced proinflammatory mediator production in fibroblast-like synoviocytes. Arthritis Research & Therapy 10: R41.
Mo, X.R., J.W. Xie, G.J. Lv, Y.P. Ke, and X.J. Luo. 2017. Effects of TAK gene silencing on the expressions of IL-6 and IL-8 induced by TNF-alpha in fibroblast-like synoviocytes. Zhongguo Ying Yong Sheng Li Xue Za Zhi 33: 471–475.
Zhang, J., F.F. Gao, and J. Xie. 2021. LncRNA linc00152/NF-kappaB feedback loop promotes fibroblast-like synovial cells inflammation in rheumatoid arthritis via regulating miR-103a/TAK1 axis and YY1 expression. Immun Inflamm Dis 9: 681–693.
Li, G., Y. Zhang, Y. Qian, H. Zhang, S. Guo, M. Sunagawa, T. Hisamitsu, and Y. Liu. 2013. Interleukin-17A promotes rheumatoid arthritis synoviocytes migration and invasion under hypoxia by increasing MMP2 and MMP9 expression through NF-kappaB/HIF-1alpha pathway. Molecular Immunology 53: 227–236.
Hui, W., C. Zhao, and S.G. Bourgoin. 2017. Differential effects of inhibitor combinations on lysophosphatidic acid-mediated chemokine secretion in unprimed and tumor necrosis factor-alpha-primed synovial fibroblasts. Frontiers in Pharmacology 8: 848.
Fabre, C., G. Carvalho, E. Tasdemir, T. Braun, L. Ades, J. Grosjean, S. Boehrer, D. Metivier, S. Souquere, G. Pierron, P. Fenaux, and G. Kroemer. 2007. NF-kappaB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 26: 4071–4083.
Taylor, C.T., and E.P. Cummins. 2009. The role of NF-kappaB in hypoxia-induced gene expression. Annals of the New York Academy of Sciences 1177: 178–184.
Maxwell, P.J., R. Gallagher, A. Seaton, C. Wilson, P. Scullin, J. Pettigrew, I.J. Stratford, K.J. Williams, P.G. Johnston, and D.J. Waugh. 2007. HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 26: 7333–7345.
Akimoto, R., T. Tanaka, T. Nakano, Y. Hozumi, K. Kawamae, and K. Goto. 2020. DGKzeta depletion attenuates HIF-1alpha induction and SIRT1 expression, but enhances TAK1-mediated AMPKalpha phosphorylation under hypoxia. Cellular Signalling 71: 109618.
Lee, Y.A., H.M. Choi, S.H. Lee, S.J. Hong, H.I. Yang, M.C. Yoo, and K.S. Kim. 2012. Hypoxia differentially affects IL-1beta-stimulated MMP-1 and MMP-13 expression of fibroblast-like synoviocytes in an HIF-1alpha-dependent manner. Rheumatology (Oxford) 51: 443–450.
Ahn, J.K., E.M. Koh, H.S. Cha, Y.S. Lee, J. Kim, E.K. Bae, and K.S. Ahn. 2008. Role of hypoxia-inducible factor-1alpha in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 834–839.
Charbonneau, M., K. Harper, F. Grondin, M. Pelmus, P.P. McDonald, and C.M. Dubois. 2007. Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. Journal of Biological Chemistry 282: 33714–33724.
Islam, S.M.T., J. Won, M. Khan, M.D. Mannie, and I. Singh. 2021. Hypoxia-inducible factor-1 drives divergent immunomodulatory functions in the pathogenesis of autoimmune diseases. Immunology 164: 31–42.
Taylor, C.T., G. Doherty, P.G. Fallon, and E.P. Cummins. 2016. Hypoxia-dependent regulation of inflammatory pathways in immune cells. The Journal of Clinical Investigation 126: 3716–3724.
Li, X., H. Kimura, K. Hirota, K. Kasuno, K. Torii, T. Okada, H. Kurooka, Y. Yokota, and H. Yoshida. 2005. Synergistic effect of hypoxia and TNF-alpha on production of PAI-1 in human proximal renal tubular cells. Kidney International 68: 569–583.
Lee, S.H., Y.J. Lee, and H.J. Han. 2010. Effect of arachidonic acid on hypoxia-induced IL-6 production in mouse ES cells: Involvement of MAPKs, NF-kappaB, and HIF-1alpha. Journal of Cellular Physiology 222: 574–585.
Cetin, A., T. Kaya, N. Demirkoprulu, B. Karadas, B. Duran, and M. Cetin. 2004. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium. Journal of Pharmacological Sciences 94: 19–24.
Flores-Costa, R., J. Alcaraz-Quiles, E. Titos, C. Lopez-Vicario, M. Casulleras, M. Duran-Guell, B. Rius, A. Diaz, K. Hall, C. Shea, R. Sarno, M. Currie, J.L. Masferrer, and J. Claria. 2018. The soluble guanylate cyclase stimulator IW-1973 prevents inflammation and fibrosis in experimental non-alcoholic steatohepatitis. British Journal of Pharmacology 175: 953–967.
Rius, J., M. Guma, C. Schachtrup, K. Akassoglou, A.S. Zinkernagel, V. Nizet, R.S. Johnson, G.G. Haddad, and M. Karin. 2008. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453: 807–811.
Culver, C., A. Sundqvist, S. Mudie, A. Melvin, D. Xirodimas, and S. Rocha. 2010. Mechanism of hypoxia-induced NF-kappaB. Molecular and Cellular Biology 30: 4901–4921.
Lian, L.H., Q. Jin, S.Z. Song, Y.L. Wu, T. Bai, S. Jiang, Q. Li, N. Yang, and J.X. Nan. 2013. Ginsenoside Rh2 downregulates LPS-induced NF- kappa B activation through inhibition of TAK1 phosphorylation in RAW 264.7 murine macrophage. Evidence-Based Complementary and Alternative Medicine 2013: 646728.
Zhou, Y., T. Tao, G. Liu, X. Gao, Y. Gao, Z. Zhuang, Y. Lu, H. Wang, W. Li, L. Wu, D. Zhang, and C. Hang. 2021. TRAF3 mediates neuronal apoptosis in early brain injury following subarachnoid hemorrhage via targeting TAK1-dependent MAPKs and NF-kappaB pathways. Cell Death & Disease 12: 10.
留言 (0)